Epidemiology of Streptococcus pneumoniae

Medecine et Maladies Infectieuses

Volumn 42, Issue 8, 2012, Pages 361-365

  Varon, E ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Invasive pneumococcal infection; Pneumococcal conjugate vaccine; Streptococcus pneumonia

Indexed keywords

AMOXICILLIN; CEFOTAXIME; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; DEFENSE MECHANISM; DISEASE SURVEILLANCE; FRANCE; HOMOLOGOUS RECOMBINATION; HUMAN; INCIDENCE; INNATE IMMUNITY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCRIPTION; PUBLIC HEALTH PROBLEM; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

DRUG RESISTANCE, BACTERIAL; FRANCE; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84864622590     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.04.002     Document Type: Article

References (11)

1. Varon E, Janoir C, Gutmann L. CNRP, Rapport d'activité 2009. http://www.invs.sante.fr/surveillance/cnr/rapport_cnrp_2009.pdf.
2. Loulergue P., Burgel P.R., Carrat F., Fritzell B., Guthmann J.P., Locht C., et al. Report of the 2nd French clinical vaccinology meeting Jean-Gérard Guillet: immunization and respiratory diseases. Vaccine 2010, 28:6551-6555.
3. Sabuncu E., David J., Bernede-Bauduin C., Pepin S., Leroy M., Boelle P.Y., et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009, 6:e1000084.
4. Lepoutre A., Varon E., Georges S., Gutmann L., Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008, 13(35). pii=18962. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18962.
5. Gaudelus J., Cohen R., Hovart J. évolution de la couverture vaccinale du vaccin pneumococcique heptavalent conjugué de 2006 à 2008: analyse des carnets de santé. Med Enfance 2009, 29:151-154.
6. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201:32-41.
7. Cohen R., Levy C., Bonnet E., Grondin S., Desvignes V., Lecuyer A., et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28:6114-6121.
8. Coffey T.J., Enright M.C., Daniels M., Morona J.K., Morona R., Hryniewicz W., et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol 1998, 27:73-83.
9. Trzcinski K., Thompson C.M., Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol 2004, 186:3447-3452.
10. Brueggemann A.B., Pai R., Crook D.W., Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007, 3:e168.
11. Pillai D.R., Shahinas D., Buzina A., Pollock R.A., Lau R., Khairnar K., et al. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009, 30(10):642.